INTRAOPERATIVE PHOTODYNAMIC THERAPY IN GASTRIC CANCER PATIENTS by E. V. Filonenko, A. D. Kaprin, E. A. Suleymanov, A. N. Urlova, V. M. Khomyakov, L. A. Vashakmadze, V. V. Sokolov, N. V. Kirillov

“…The study included 240 patients with gastric cancer stage II-IV (Т3-4N0-3M0-1) with  evident or suspected peritoneal dissemination who underwent  examination and treatment in P.Herzen Moscow Oncology Research  Institute. …”
Get full text

Rectal stimulation with prebiotics and probiotics before ileostomy reversal: a study protocol for a randomized controlled trial by Marília Marcelino, Francisco Tustumi, Lucas Soares Gerbasi, Rafael Vaz Pandini, Rafaela de Souza Novo, Marleny Novaes Figueiredo de Araujo, Elis Oliveira, Victor Edmond Seid, Sergio Eduardo Alonso Araujo

“…The following criteria will be used for inclusion: adult patients with rectal cancer stages cT3/4Nx or cTxN+ that underwent loop protection ileostomy, patients treated with neoadjuvant chemoradiotherapy, and patients who underwent laparoscopic or robotic total mesorectal excision. …”
Get full text

Dendritic cell vaccination in combination with erlotinib in a patient with inoperable lung adenocarcinoma: a case report by Takuya Kosumi, Masanori Kobayashi, Shigetaka Shimodaira, Haruo Sugiyama, Shigeo Koido

“…We report a case of unresectable advanced lung cancer (stage IIIb: T2aN3M0) treated with a total of 15 doses of dendritic cells pulsed with a Wilms’ tumor 1 and mucin 1 vaccine in combination with erlotinib, a small molecule epidermal growth factor receptor tyrosine kinase inhibitor, for more than 699 days without recurrence or metastasis. …”
Get full text

Study of the protective effects of cyanocobalamin on methotrexate induced nephrotoxicity in rats [version 2; peer review: 2 approved] by Samara Muwafaq Ali Alabdali, Rana Q. Abdulwahhab

“…Background: Methotrexate (MTX) is a chemotherapeutic drug, used mainly in many cancerous stages, inflammatory and auto-immune diseases, but its use has been limited by its nephrotoxicity. …”
Get full text

T cell-mediated tumor killing sensitivity gene signature-based prognostic score for acute myeloid leukemia by Yiyun Pan, FangFang Xie, Wen Zeng, Hailong Chen, Zhengcong Chen, Dechang Xu, Yijian Chen

“…Higher TTKPI scores were associated with older age and cancer stage, which showed improved prognostic performance when combined with TTKPI. …”
Get full text

Factors associated with the breast cancer diagnostic interval across five Canadian provinces: a CanIMPACT study by Mary McBride, Patti Groome, Kathleen Decker, Eva Grunfeld, Li Jiang, Cynthia Kendell, Robin Urquhart, Khanh Vu, Marcy Winget

“…Stratified by these two diagnostic routes, we describe the variation in the interval across provinces and report on the province-specific associations between the diagnostic interval and: patient age, comorbid disease burden, socioeconomic status combined with rural residence, and continuity of primary care while controlling for cancer stage. Results The median diagnostic interval varied by 6 days (29 to 35 days) across provinces. …”
Get full text

Upregulation of programmed death ligand-1 in tumor-associated macrophages affects chemotherapeutic response in ovarian cancer cells. by Yong Soo Jang, Tae Wan Kim, Jae Sung Ryu, Hye Jeong Kong, Si Hyeong Jang, Gye Hyun Nam, Jae Hoon Kim, Seob Jeon

“…However, IHC results revealed no correlation between PD-L1 expression and patient survival or cancer stage. CD68 expression was significantly increased in cancer cells compared to normal or benign ovarian tumor cells, but it was not associated with the survival outcomes of ovarian cancer patients. …”
Get full text

Effect of PTGES3 on the Prognosis and Immune Regulation in Lung Adenocarcinoma by Wenyan Jiang, Qiong Wei, Haiqin Xie, Dandan Wu, Haiyan He, Xuedong Lv

“…The gene and protein expression of PTGES3 were elevated in LUAD tissues and compared to the normal tissues, and the high expression of PTGES3 was correlated with cancer stage and tumor grade. Survival analysis revealed that overexpression of PTGES3 was associated with poor prognosis of LUAD patients. …”
Get full text

Factors influencing receipt and time to treatment of immunotherapy relative to chemotherapy in stage III and stage IV melanoma by Gurman S. Dhaliwal, Ahmad B. Shahin, Elisabeth S. Lim, Lanyu Mi, Aaron R. Mangold, David L. Swanson, Collin M. Costello

“…In multivariable logistic regression analysis, factors significantly associated with immunotherapy receipt included population density, circle distance, year of diagnosis, Breslow thickness, and cancer stage. Immunotherapy timing was evaluated using multivariable Cox regression analysis. …”
Get full text

The effect and therapeutic compliance of adjuvant therapy in patients with cholangiocarcinoma after R0 resection: a retrospective study by Han Taek Jeong, Joonkee Lee, Hyeong Ho Jo, Ho Gak Kim, Jimin Han

“…American Society of Anesthesiologists classification II (HR, 0.50; 95% CI, 0.31–0.81; p=0.005), and American Joint Committee on Cancer stages II (HR, 3.14; 95% CI, 1.25–7.89; p=0.015) and III (HR, 8.08; 95% CI, 2.80–23.32; p<0.001) were independent predictors of PFS. …”
Get full text

Failure of hepatocellular carcinoma surveillance: inadequate echogenic window and macronodular parenchyma as potential culprits by Yeun-Yoon Kim, Chansik An, Do Young Kim, Khalid Suliman Aljoqiman, Jin-Young Choi, Myeong-Jin Kim

“…The quality of the echogenic window, macronodularity of the liver parenchyma, and occurrence of surveillance failure (initial tumor diagnosis beyond the Milan criteria or at Barcelona Clinic Liver Cancer stage B or C) were evaluated. Overall survival was compared according to whether surveillance failure occurred. …”
Get full text

Initial study of learning curves in robot-assisted radical prostatectomy by Le Chuyen Vu, Vinh Hung Tran, Phuc Cam Hoang Nguyen, Van An Nguyen, Vu Phuong Do, Ngoc Chau Nguyen, Lenh Hung Do

“…Research variables were cancer stage, preand postoperative prostate-specific antigen (PSA) serum levels, Gleason scores, lymph node metastasis, estimated blood loss, surgery time, urinary incontinence, hospital stay, and complications. …”
Get full text

NEW BIOCHEMICAL MARKERS OF RECURRENCE OF PROSTATE CANCER AFTER HIS TREATMENT by M. B. Chibichyan, E. A. Chernogubova, M. I. Kogan

“…Group II included 8 patients after RPE with development of BR. The prostate cancer stage in Group II was as follows: рT3 in 7 patients, and pT4 in one patient. …”
Get full text

The oncological and obstetric results of radical trachelectomy as a fertility-sparing therapy in early-stage cervical cancer patients by Tao Chen, Jia Li, Yan Zhu, An-Wei Lu, Li Zhou, Jian-San Wang, Ying Zhang, Jun-Tao Wang

“…Methods A retrospective analysis was conducted the oncological and obstetric results of 23 patients with early cervical cancer (stages IA2–IB3; International Federation of Gynecology and Obstetrics, 2018) who underwent RT in The Maternal and Child Health Care Hospital of Guiyang, China, from October 2004 to September 2018. …”
Get full text

Prospects of Artificial Intelligence in the Improvement of Healthcare Professions: A Review by Dr Tanveer Khan, Muhammad Masood Ahmad, Muhammad Usman Munir, Syed Nasir Abbas Bukhari, Muhammad Ayub Naveed

“…It helps the diagnosis of cancer stages based on the abnormal cell growth in the brain. …”
Get full text

Unveiling the hub genes in the SIGLECs family in colon adenocarcinoma with machine learning by Tiantian Li, Ji Yao, Ji Yao

“…We find any single SIGLEC is uncorrelated to the cancer stages, which can be significantly improved by using PCA. …”
Get full text

Lymph node ratio predicts overall survival in patients with stage II non-small cell lung cancer: a population-based SEER analysis by Nan Feng, Bo Wu, Xiang Zhang, Jianhui Chen, Zhongtian Xiang, Yiping Wei, Wenxiong Zhang

Get full text

Time to diagnosis and treatment in younger adults with colorectal cancer: A systematic review. by Matthew Castelo, Colin Sue-Chue-Lam, Lawrence Paszat, Teruko Kishibe, Adena S Scheer, Bettina E Hansen, Nancy N Baxter

“…In four studies reporting the relationship between intervals and cancer stage or survival, there were no clear associations between longer intervals and adverse outcomes.…”
Get full text

Experience in the treatment of radioinduced angiosarcoma of the breast in a patient with primary multiple lesions of the breast and bladder. Case report by Edward V. Semenov, Dyunya D. Gasymly, Alena V. Zyuzyukina, Ruslan A. Zukov

“…The article presents a clinical case of a female patient born in 1952, who was diagnosed with synchronous multiple primary cancer in 2014: stage 2A left breast cancer (cT2N0M0); bladder cancer stage I (cT1cN0M0). After the complex treatment, the patient received adjuvant endocrine therapy with Tamoxifen. …”
Get full text

Socio-economic variations of breast cancer treatment and discontinuation: a study from a public tertiary cancer hospital in Mumbai, India by Sanjay K. Mohanty, Tabassum Wadasadawala, Soumendu Sen, Pijush Kanti Khan

“…Patients who did not have any health insurance, never attended school, cancer stage IV had a higher percentage of treatment discontinuation due to financial crisis. …”
Get full text